Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung is a research paper published in Nucleic Acids Research (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cystic Fibrosis Foundation
Grant: KREDA16G0
Cystic Fibrosis Foundation
Grant: KREDA19I0
Cystic Fibrosis Foundation
Grant: KREDA20G0
National Institutes of Health
Grant: 1 R41 TR002692-01
Correction of Splicing Defects in Cystic Fibrosis with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
Small Business Innovation Research
Grant: R44 TR002692-02
Cystic Fibrosis Foundation
Grant: BOUCHE19R0
National Institutes of Health
Grant: P30DK065988
National Cancer Institute
Grant: CA16086
NCATS NIH HHS
Grant: R44 TR002692
NCATS NIH HHS
Grant: R41 TR002692
NCI NIH HHS
Grant: P30 CA016086
National Institutes of Health
Grant: 5R44TR002692-03
Therapy of Pulmonary Diseases with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
National Institutes of Health
Grant: 3P30DK065988-10S1
Correction Core
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
UNC-CF Center Cores
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals